tiprankstipranks
Trending News
More News >
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX
Advertisement

Insight Molecular Diagnostics (IMDX) Revenue

Compare
430 Followers

Insight Molecular Diagnostics Revenue

Insight Molecular Diagnostics had a revenue of 260.00K in the quarter ending Sep 30, 2025, with -49.81%. This bring the company's revenue in the last twelve months to 4.40M, Decreased 3.41%. In the fiscal year ending Dec 31, 2024, Insight Molecular Diagnostics had annual revenue of 1.88M with 25.15% growth.
Revenue (ttm)
4.40M
Revenue Growth
520.87%
P/S Ratio
93.27
Revenue/Employee
$40,891
Employees
46
Market Cap
$175.44M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
1.88M378.00K+125.15%
Dec 31, 2023
1.50M545.00K+156.89%
Dec 31, 2022
958.00K-1.24M+43.59%
Dec 31, 2021
2.20M982.00K+180.76%
Dec 31, 2020
1.22M-121,600,000.00%
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis